miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer

MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?

(2015) Geraldine Cizeron-Clairac et al.   BMC CANCER

Analysis of the TGFβ-induced program in primary airway epithelial cells shows essential role of NF-κB/RelA signaling network in type II epithelial mesenchymal transition

(2015) Bing Tian et al.   BMC GENOMICS

Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes

(2015) Yan Liu et al.   BREAST CANCER RESEARCH AND TREATMENT

miR-30e* is an independent subtype-specific prognostic marker in breast cancer

(2015) F D'Aiuto et al.   BRITISH JOURNAL OF CANCER

Clinical implications of epithelial cell plasticity in cancer progression

(2015) Luis A. Aparicio et al.   CANCER LETTERS

Network-Based Approaches to Understand the Roles of miR-200 and Other microRNAs in Cancer

(2015) C. P. Bracken et al.   CANCER RESEARCH

RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma

(2015) Wei Guo et al.   CLINICAL & EXPERIMENTAL METASTASIS

Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma

(2015) DH Jensen et al.   JOURNAL OF PATHOLOGY

Zfra activates memory Hyal-2+ CD3- CD19- spleen cells to block cancer growth, stemness, and metastasis in vivo

(2015) Ming-Hui Lee et al.   Oncotarget

MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1

(2015) Kang Han et al.   Oncotarget

MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling

(2015) Na Huang et al.   Oncotarget

Absolute quantification of cell-free microRNAs in cancer patients

(2015) Manuela Ferracin et al.   Oncotarget

MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer

(2015) Ross M. Drayton et al.   Oncotarget

Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration

(2015) Amelie Hailer et al.   Oncotarget

The Roles of the Epithelial-Mesenchymal Transition Marker PRRX1 and miR-146b-5p in Papillary Thyroid Carcinoma Progression

(2014) Heather Hardin et al.   AMERICAN JOURNAL OF PATHOLOGY

Dual specificity phosphatase 4 gene expression in association with triple-negative breast cancer outcome

(2014) Michelle L. Baglia et al.   BREAST CANCER RESEARCH AND TREATMENT

XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism

(2014) Sripathi M. Sureban et al.   CANCER LETTERS

MiR-124 Radiosensitizes Human Colorectal Cancer Cells by Targeting PRRX1

(2014) Yuqin Zhang et al.   PLoS One

Paired related homoeobox 1, a new EMT inducer, is involved in metastasis and poor prognosis in colorectal cancer

(2013) Y Takahashi et al.   BRITISH JOURNAL OF CANCER

MiR-134/487b/655 Cluster Regulates TGF- -Induced Epithelial-Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting MAGI2 in Lung Adenocarcinoma Cells

(2013) K. Kitamura et al.   MOLECULAR CANCER THERAPEUTICS

Cancer: The to and fro of tumour spread

(2013) Bryce J. W. van Denderen et al.   NATURE

miR-655 Is an EMT-Suppressive MicroRNA Targeting ZEB1 and TGFBR2

(2013) Yosuke Harazono et al.   PLoS One

Metastatic Colonization Requires the Repression of the Epithelial-Mesenchymal Transition Inducer Prrx1

(2012) Oscar H. Ocaña et al.   CANCER CELL

Evidence for a partial epithelial–mesenchymal transition in postnatal stages of rat auditory organ morphogenesis

(2012) Nicolas Johnen et al.   HISTOCHEMISTRY AND CELL BIOLOGY